scholarly article | Q13442814 |
P356 | DOI | 10.3748/WJG.V18.I15.1708 |
P8608 | Fatcat ID | release_gw6opkgmprevzfxsunedlbjzby |
P932 | PMC publication ID | 3332284 |
P698 | PubMed publication ID | 22553395 |
P5875 | ResearchGate publication ID | 224889122 |
P2093 | author name string | Xiaofa Qin | |
P2860 | cites work | Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review | Q22250934 |
Recent Insights Into the Genetics of Inflammatory Bowel Disease | Q22250935 | ||
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis | Q22251072 | ||
Review of harmful gastrointestinal effects of carrageenan in animal experiments | Q24530196 | ||
Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats | Q28570040 | ||
Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 | ||
Inflammatory bowel disease | Q29615500 | ||
Genetics and pathogenesis of inflammatory bowel disease | Q29616350 | ||
Epidemiology and natural history of inflammatory bowel diseases | Q29619945 | ||
Artificial sweeteners--do they bear a carcinogenic risk? | Q33206814 | ||
Human gut microbiome: the second genome of human body | Q33785030 | ||
Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. | Q33828573 | ||
Crohn's disease in Stockholm County during 1990-2001: an epidemiological update | Q33829937 | ||
Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease | Q33956828 | ||
Gut microbiota: a new aspect that should be taken into more consideration when assessing the toxicity of chemicals or the adverse effects and efficacy of drugs | Q81304407 | ||
Synergic effect of bacterial glycosidases and digestive proteases on mucus degradation and the reduced risk of inflammatory bowel disease-like gut damage in both germ-free and poor hygiene conditions | Q81412991 | ||
What caused the extra high incidence of inflammatory bowel disease in the industrialized countries in the West: lack of some nutrients or increased intake of some harmful agents? | Q81722345 | ||
Ulcerative colitis in the county of Uppsala 1945-2007: incidence and clinical characteristics | Q82690822 | ||
Can meat and protein really increase, while vegetables and fruits decrease the risk of inflammatory bowel disease? How? | Q82963561 | ||
How can we really reduce the morbidity of inflammatory bowel disease - Research on genes and cytokines, or find out the causative factors in the environment? | Q82963722 | ||
A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease | Q83131515 | ||
Food additives: possible cause for recent remarkable increase of inflammatory bowel disease in children | Q83747358 | ||
The effect of dietary chemicals on gut bacteria and IBD demands further study | Q83757072 | ||
Ulcerative Colitis | Q83845928 | ||
Inflammatory bowel disease: an update on the fundamental biology and clinical management | Q84002915 | ||
What caused the recent worldwide increase of inflammatory bowel disease: should sucralose be added as a suspect? | Q84523744 | ||
DISCUSSION ON ULCERATIVE COLITIS | Q85038554 | ||
A Discussion on Ulcerative Colitis | Q93864842 | ||
Inflammatory bowel disease: the role of environmental factors | Q33980373 | ||
The epidemiology of inflammatory bowel disease in Canada: a population-based study | Q33997864 | ||
Crohn's disease: the cold chain hypothesis. | Q34284767 | ||
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective | Q34286549 | ||
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87 | Q34375445 | ||
Crohn's disease in the city of Derby, 1951-85. | Q34393035 | ||
What made Canada become a country with the highest incidence of inflammatory bowel disease: could sucralose be the culprit? | Q34632250 | ||
Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease | Q34632535 | ||
Measles, mumps and rubella vaccine, autism and inflammatory bowel disease: advising concerned parents | Q34880787 | ||
A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India | Q35002616 | ||
Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? | Q35065315 | ||
Familial aggregation in inflammatory bowel disease: is it genes or environment? | Q35068954 | ||
Inflammatory bowel disease incidence: up, down or unchanged? | Q35349893 | ||
Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? | Q35565556 | ||
A review and biological risk assessment of sodium saccharin | Q35748694 | ||
Incidence of Crohn's disease in Stockholm County 1955-1989. | Q35841190 | ||
Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators | Q36066805 | ||
Historical origins of current IBD concepts | Q36491953 | ||
High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study | Q36609199 | ||
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America | Q36802273 | ||
IDIOPATHIC ULCERATIVE COLITIS: A REVIEW OF 149 CASES WITH PARTICULAR REFERENCE TO THE VALUE OF, AND INDICATIONS FOR SURGICAL TREATMENT. | Q36940705 | ||
Helminths and the IBD hygiene hypothesis | Q37235236 | ||
Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review | Q37496554 | ||
Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality? | Q37587778 | ||
Pediatric inflammatory bowel disease: is it different? | Q37604727 | ||
Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. | Q37733066 | ||
Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy | Q37795103 | ||
Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. | Q38138277 | ||
Inflammatory bowel disease in northern Alberta. An epidemiologic study | Q39294428 | ||
CHRONIC ULCERATIVE COLITIS. | Q39712107 | ||
Future of IBD pathogenesis: how much work is left to do? | Q40042878 | ||
Ulcerative colitis: definition, historical background, aetiology, diagnosis, naturel history and local complications | Q40348424 | ||
The development and applications of sucralose, a new high-intensity sweetener | Q40630596 | ||
Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues. | Q41213146 | ||
Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence | Q41851215 | ||
Microparticles in Crohn's disease--has the dust settled? | Q42118818 | ||
Surgery for inflammatory bowel disease | Q42122954 | ||
High incidence of inflammatory bowel disease with improved hygiene and failure to get human-like IBD in laboratory animals | Q42547323 | ||
Inactivation of digestive proteases by deconjugated bilirubin: the possible evolutionary driving force for bilirubin or biliverdin predominance in animals | Q42634912 | ||
What caused the increase of autoimmune and allergic diseases: a decreased or an increased exposure to luminal microbial components? | Q42846637 | ||
Inactivation of digestive proteases: another aspect of gut bacteria that should be taken into more consideration | Q42846896 | ||
The absence of genotoxicity of sucralose | Q42944124 | ||
Impaired inactivation of digestive proteases: a factor that may have confounded the efficacy of antibiotics aimed at reducing the exposure to luminal bacteria and their components | Q43441764 | ||
Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease | Q43788270 | ||
Intestinal permeability in patients with Crohn's disease and their healthy relatives | Q43863082 | ||
Antibiotic use and inflammatory bowel diseases in childhood | Q43947206 | ||
Epidemiology of inflammatory bowel disease in the county of Tübingen (West Germany). | Q44054970 | ||
Impaired inactivation of digestive proteases by deconjugated bilirubin: the possible mechanism for inflammatory bowel disease | Q44123183 | ||
Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease | Q44247096 | ||
Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987 | Q44381829 | ||
Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners | Q44754300 | ||
An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence | Q45349612 | ||
Sucralose screening in European surface waters using a solid-phase extraction-liquid chromatography-triple quadrupole mass spectrometry method | Q46171026 | ||
Ulcerative colitis in the United States Army in 1944. Epidemiology: comparisons between patients and controls. | Q46621474 | ||
Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis | Q47249731 | ||
Inactivation of Digestive Proteases by Deconjugated Bilirubin and the Physiological Significance of Fasting Hyperbilirubinemia | Q49473920 | ||
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. | Q50543867 | ||
Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. | Q50546085 | ||
The incidence of Crohn's disease is not decreasing in Sweden. | Q50547388 | ||
A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. | Q50718629 | ||
Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. | Q50795640 | ||
Epidemiology of Crohn's disease in Québec, Canada. | Q51677583 | ||
The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005. | Q51728016 | ||
News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010. | Q51775003 | ||
THE SURGICAL TREATMENT OF CHRONIC ULCERATIVE COLITIS. | Q54223695 | ||
Where are the weapons of mass destruction − the Mycobacterium paratuberculosis in Crohn's disease? | Q54337310 | ||
Environmental risk factors in Crohn's disease and ulcerative colitis: an update | Q63284654 | ||
Sugar substitutes | Q66908394 | ||
Sigma diagnostics: pioneer of kits for clinical chemistry | Q70692492 | ||
Changes in the incidence of inflammatory bowel disease: what does it mean? | Q74249433 | ||
Usage of saccharin in food products and its intake by the population of Lucknow, India | Q79374389 | ||
Is the incidence of inflammatory bowel disease in the developed countries increasing again? Is that surprising? | Q79502816 | ||
The epidemiology and clinical characteristics of Crohn's disease in the Hong Kong Chinese population: experiences from a regional hospital | Q80142175 | ||
The etiology and treatment of chronic ulcerative colitis (non-specific) | Q80354260 | ||
Primary sclerosing cholangitis and inflammatory bowel disease: where is the link? | Q80388958 | ||
Reduced production of digestive proteases and the efficacy of enteral and parenteral nutrition on inflammatory bowel disease | Q80504909 | ||
Inhibition of gut bacteria by dietary chemicals and the hygiene hypothesis | Q80547265 | ||
What is human inflammatory bowel disease (IBD) more like: Johne's disease in cattle or IBD in dogs and cats? | Q80752608 | ||
Inactivation of digestive proteases: another mechanism that probiotics may have conferred a protection | Q80863285 | ||
Has Crohn's disease really occurred anywhere in the digestive tract? | Q81001365 | ||
With the great complexity unveiling, can we still decipher the interaction between gut flora and the host in inflammatory bowel disease to find out the mechanism and cause? How? | Q81110702 | ||
ULCERATIVE COLITIS | Q81287130 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
inflammatory bowel diseases | Q917447 | ||
P304 | page(s) | 1708-22 | |
P577 | publication date | 2012-04-21 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Etiology of inflammatory bowel disease: a unified hypothesis | |
P478 | volume | 18 |
Q63352768 | A Novel Rare Missense Variation of the Gene: Evidencesof Implication in Crohn's Disease |
Q92832933 | A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice |
Q54415163 | Comment on: paediatric inflammatory bowel disease in a multiracial Asian country. |
Q35755435 | Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways |
Q53580452 | Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). |
Q36819630 | Difference in DRB1* gene polymorphisms between Han and Uyghur ulcerative colitis patients in China |
Q27015979 | ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation |
Q37118873 | Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis |
Q27028109 | Fast food fever: reviewing the impacts of the Western diet on immunity |
Q40744896 | Fluoride: a risk factor for inflammatory bowel disease? |
Q93176480 | High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease |
Q43081327 | How to explain recent multiple reports on the decline of inflammatory bowel disease in Canada |
Q35012018 | Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review |
Q39157293 | Impaired inactivation of digestive proteases: The possible key factor for the high susceptibility of germ-free and antibiotic-treated animals to gut epithelial injury |
Q53580450 | Inactivation of Digestive Proteases and Degradation of Mucus: The Possible Key Factors That Determined the Different Effects on the Gut by Antibiotics. |
Q40613647 | Increased Digestive Proteases and Decreased β-Glucuronidase in Feces of Rats Treated with Sucralose and Saccharin-Another Critical Evidence That These Dietary Chemicals May Be Important Causative Factors for Inflammatory Bowel Disease |
Q53755976 | Increased Milk Consumption but Decreased Risk of Crohn's Disease (CD): Critical Evidence Negated Causative Role of Mycobacterium avium Subspecies paratuberculosis (MAP) in CD. |
Q35012080 | Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil |
Q38810502 | Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel |
Q42905587 | May bacterial or pancreatic proteases play a critical role in inflammatory bowel disease? |
Q44304473 | Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis. |
Q85843857 | Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis |
Q38106116 | QSAR methods for the discovery of new inflammatory bowel disease drugs |
Q92156587 | Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin |
Q38293574 | Review article: breath analysis in inflammatory bowel diseases |
Q34657381 | Sucralose, a synthetic organochlorine sweetener: overview of biological issues |
Q88803580 | Suppression of methionine-induced colon injury of young rats by cysteine and N-acetyl-L-cysteine |
Q52648684 | The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis. |
Q33923735 | The Myc 3' Wnt responsive element regulates neutrophil recruitment after acute colonic injury in mice |
Q26825483 | Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier |
Q92582562 | Uncovering the cause of ulcerative colitis |
Q42411715 | What might be the cause for the emerging inflammatory bowel disease in Saudi outpatients? |
Q33356357 | Why is damage limited to the mucosa in ulcerative colitis but transmural in Crohn's disease? |
Q44527423 | Why pediatric inflammatory bowel disease (IBD) in Sweden shared similar trend of change as general population IBD in Denmark but not pediatric IBD in Norway? |